These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 25695239)
1. Tubular dysfunction and non-albuminuric renal disease in subjects with type 2 diabetes mellitus. Robles-Osorio ML; Sabath E Rev Invest Clin; 2014; 66(3):234-9. PubMed ID: 25695239 [TBL] [Abstract][Full Text] [Related]
2. Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin. Hasslacher C; Kulozik F J Diabetes; 2016 Sep; 8(5):712-9. PubMed ID: 26615054 [TBL] [Abstract][Full Text] [Related]
3. Urinary alpha1-microglobulin as a marker of nephropathy in type 2 diabetic Asian subjects in Singapore. Hong CY; Hughes K; Chia KS; Ng V; Ling SL Diabetes Care; 2003 Feb; 26(2):338-42. PubMed ID: 12547859 [TBL] [Abstract][Full Text] [Related]
4. Identification and Stratification of Diabetic Kidney Disease Using Serum Cystatin C and Serum Creatinine Based Estimating Equations in Type 2 Diabetes: A Comparative Analysis. Avinash S; Singh VP; Agarwal AK; Chatterjee S; Araya V J Assoc Physicians India; 2015 Nov; 63(11):28-35. PubMed ID: 29900708 [TBL] [Abstract][Full Text] [Related]
5. The estimated glomerular filtration rate is associated with subclinical atherosclerosis, independently of albuminuria, in patients with type 2 diabetes. Lu B; Wan J; Yang Y; Li Y; Hu R Int Angiol; 2013 Oct; 32(5):532-9. PubMed ID: 23903314 [TBL] [Abstract][Full Text] [Related]
6. Annual deterioration of renal function in hypertensive patients with and without diabetes. Polonia J; Azevedo A; Monte M; Silva JA; Bertoquini S Vasc Health Risk Manag; 2017; 13():231-237. PubMed ID: 28721063 [TBL] [Abstract][Full Text] [Related]
7. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study. Fu WJ; Xiong SL; Fang YG; Wen S; Chen ML; Deng RT; Zheng L; Wang SB; Pen LF; Wang Q Endocrine; 2012 Feb; 41(1):82-8. PubMed ID: 21779943 [TBL] [Abstract][Full Text] [Related]
8. Associations of urinary, glomerular, and tubular markers with the development of diabetic kidney disease in type 2 diabetes patients. Jiang X; Zhang Q; Wang HB; Cui XF; Liu R J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28236320 [TBL] [Abstract][Full Text] [Related]
9. The effect of the non-ionic contrast medium iohexol on glomerular and tubular function in diabetic patients. Apelqvist J; Torffvit O; Agardh CD Diabet Med; 1996 May; 13(5):487-92. PubMed ID: 8737033 [TBL] [Abstract][Full Text] [Related]
10. Urinary α Saif A; Soliman N J Diabetes; 2017 Jan; 9(1):61-64. PubMed ID: 26847470 [TBL] [Abstract][Full Text] [Related]
11. Glycaemia, arterial pressure and micro-albuminuria in type 1 (insulin-dependent) diabetes mellitus. Wiseman M; Viberti G; Mackintosh D; Jarrett RJ; Keen H Diabetologia; 1984 Jun; 26(6):401-5. PubMed ID: 6468790 [TBL] [Abstract][Full Text] [Related]
13. Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy. Brocco E; Velussi M; Cernigoi AM; Abaterusso C; Bruseghin M; Carraro A; Sambataro M; Piarulli F; Sfriso A; Nosadini R J Nephrol; 2001; 14(6):461-71. PubMed ID: 11783602 [TBL] [Abstract][Full Text] [Related]
14. Study of Angiopoietin-2 and vascular endothelial growth factor as markers of diabetic nephropathy onset in Egyptians diabetic patients with non-albuminuric state. Aly MH; Arafat MA; Hussein OA; Elsaid HH; Abdel-Hammed AR Diabetes Metab Syndr; 2019; 13(2):1623-1627. PubMed ID: 31336531 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus. Bouvet BR; Paparella CV; Arriaga SM; Monje AL; Amarilla AM; Almará AM Arq Bras Endocrinol Metabol; 2014 Nov; 58(8):798-801. PubMed ID: 25465599 [TBL] [Abstract][Full Text] [Related]
16. Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factors. Conway BR; Manoharan D; Manoharan D; Jenks S; Dear JW; McLachlan S; Strachan MW; Price JF Kidney Int; 2012 Oct; 82(7):812-8. PubMed ID: 22718188 [TBL] [Abstract][Full Text] [Related]
17. Non-albuminuric renal disease among subjects with advanced stages of chronic kidney failure related to type 2 diabetes mellitus. Boronat M; García-Cantón C; Quevedo V; Lorenzo DL; López-Ríos L; Batista F; Riaño M; Saavedra P; Checa MD Ren Fail; 2014 Mar; 36(2):166-70. PubMed ID: 24059817 [TBL] [Abstract][Full Text] [Related]
18. The kidney and cardiovascular outcome trials. Bloomgarden Z J Diabetes; 2018 Feb; 10(2):88-89. PubMed ID: 29031006 [TBL] [Abstract][Full Text] [Related]
19. High risk of tubular damage in normoalbuminuric adults with type 2 diabetes for over 14 years. Ma Y; Wang H; Shan X; Zhu F; Wang W J Diabetes; 2021 Mar; 13(3):261-264. PubMed ID: 33150688 [TBL] [Abstract][Full Text] [Related]
20. Cystatin C and cystatin glomerular filtration rate as markers of early renal disease in Asian Indian subjects with glucose intolerance (CURES-32). Surendar J; Anuradha S; Ashley B; Balasubramanyam M; Aravindhan V; Rema M; Mohan V Metab Syndr Relat Disord; 2009 Oct; 7(5):419-25. PubMed ID: 19419268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]